These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
3. Pharmacological inhibition of mitochondrial membrane permeabilization for neuroprotection. Hisatomi T; Ishibashi T; Miller JW; Kroemer G Exp Neurol; 2009 Aug; 218(2):347-52. PubMed ID: 19303007 [TBL] [Abstract][Full Text] [Related]
4. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders. Sas K; Robotka H; Toldi J; Vécsei L J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670 [TBL] [Abstract][Full Text] [Related]
6. Partial agonists as therapeutic agents at neuronal nicotinic acetylcholine receptors. Hogg RC; Bertrand D Biochem Pharmacol; 2007 Feb; 73(4):459-68. PubMed ID: 16979139 [TBL] [Abstract][Full Text] [Related]
7. Interrupting apoptosis in neurodegenerative disease: potential for effective therapy? Waldmeier PC; Tatton WG Drug Discov Today; 2004 Mar; 9(5):210-8. PubMed ID: 14980539 [TBL] [Abstract][Full Text] [Related]
8. [Current and future medical treatment of Alzheimer's disease]. Lemper JC Rev Med Brux; 2005 Sep; 26(4):S294-9. PubMed ID: 16240877 [TBL] [Abstract][Full Text] [Related]
9. Significance of molecular signaling for protein translation control in neurodegenerative diseases. Chang RC; Yu MS; Lai CS Neurosignals; 2006-2007; 15(5):249-58. PubMed ID: 17496426 [TBL] [Abstract][Full Text] [Related]
10. Pharmacological strategies for the regulation of inducible nitric oxide synthase: neurodegenerative versus neuroprotective mechanisms. Pannu R; Singh I Neurochem Int; 2006 Jul; 49(2):170-82. PubMed ID: 16765486 [TBL] [Abstract][Full Text] [Related]
12. Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases. Barchet TM; Amiji MM Expert Opin Drug Deliv; 2009 Mar; 6(3):211-25. PubMed ID: 19290842 [TBL] [Abstract][Full Text] [Related]
13. Oxidative stress and the pathogenesis of neurodegenerative disorders. Reynolds A; Laurie C; Mosley RL; Gendelman HE Int Rev Neurobiol; 2007; 82():297-325. PubMed ID: 17678968 [TBL] [Abstract][Full Text] [Related]
15. Dining in with BCL-2: new guests at the autophagy table. Germain M; Slack RS Clin Sci (Lond); 2009 Oct; 118(3):173-81. PubMed ID: 19845510 [TBL] [Abstract][Full Text] [Related]
16. Modulating apoptosis as a target for effective therapy. Fleischer A; Ghadiri A; Dessauge F; Duhamel M; Rebollo MP; Alvarez-Franco F; Rebollo A Mol Immunol; 2006 Mar; 43(8):1065-79. PubMed ID: 16099509 [TBL] [Abstract][Full Text] [Related]
17. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia. Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810 [TBL] [Abstract][Full Text] [Related]
18. Drosophila in the study of neurodegenerative disease. Marsh JL; Thompson LM Neuron; 2006 Oct; 52(1):169-78. PubMed ID: 17015234 [TBL] [Abstract][Full Text] [Related]
19. Chromatin acetylation status in the manifestation of neurodegenerative diseases: HDAC inhibitors as therapeutic tools. Anne-Laurence B; Caroline R; Irina P; Jean-Philippe L Subcell Biochem; 2007; 41():263-93. PubMed ID: 17484132 [TBL] [Abstract][Full Text] [Related]
20. Flavopiridol: an antitumor drug with potential application in the treatment of neurodegenerative diseases. Pallàs M; Verdaguer E; Jordà EG; Jiménez A; Canudas AM; Camins A Med Hypotheses; 2005; 64(1):120-3. PubMed ID: 15533627 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]